Financials Biohit Oyj

Equities

BIOBV

FI0009005482

Office Equipment

Market Closed - Nasdaq Helsinki 10:45:35 2024-04-26 am EDT 5-day change 1st Jan Change
2.02 EUR +1.25% Intraday chart for Biohit Oyj -1.46% +7.16%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 27.61 23.62 28.49 30.65 - -
Enterprise Value (EV) 1 27.61 23.62 28.49 22.25 20.65 30.65
P/E ratio -18.4 x 39.3 x 15.7 x 15.5 x 15.5 x 13.5 x
Yield - - - - - -
Capitalization / Revenue - - 2.17 x 2 x 1.76 x 1.56 x
EV / Revenue - - 2.17 x 1.45 x 1.19 x 1.56 x
EV / EBITDA - - 12.9 x 9.67 x 7.38 x 9.01 x
EV / FCF - - - 6.18 x 12.9 x 18 x
FCF Yield - - - 16.2% 7.75% 5.55%
Price to Book - - - 2.66 x 2.27 x -
Nbr of stocks (in thousands) 15,046 15,046 15,114 15,174 - -
Reference price 2 1.835 1.570 1.885 2.020 2.020 2.020
Announcement Date 2/16/22 2/15/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - - 13.1 15.3 17.4 19.7
EBITDA 1 - - 2.2 2.3 2.8 3.4
EBIT 1 - - 1.8 1.9 2.5 2.8
Operating Margin - - 13.74% 12.42% 14.37% 14.21%
Earnings before Tax (EBT) 1 - - 2.2 2.1 2.5 2.8
Net income 1 -1.5 0.6 1.9 1.9 2 2.3
Net margin - - 14.5% 12.42% 11.49% 11.68%
EPS 2 -0.1000 0.0400 0.1200 0.1300 0.1300 0.1500
Free Cash Flow 1 - - - 3.6 1.6 1.7
FCF margin - - - 23.53% 9.2% 8.63%
FCF Conversion (EBITDA) - - - 156.52% 57.14% 50%
FCF Conversion (Net income) - - - 189.47% 80% 73.91%
Dividend per Share 2 - - - - - -
Announcement Date 2/16/22 2/15/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 6.5 6.6 7.6 7.7 8.6 8.8
EBITDA 1 1.7 0.5 1.2 1.1 1.3 1.2
EBIT 1 1.5 0.3 1 0.9 1.3 1.2
Operating Margin 23.08% 4.55% 13.16% 11.69% 15.12% 13.64%
Earnings before Tax (EBT) 1 1.7 0.5 1.1 1 1.3 1.2
Net income 1 1.4 0.5 1 0.9 1.3 1.2
Net margin 21.54% 7.58% 13.16% 11.69% 15.12% 13.64%
EPS 2 0.0900 0.0300 0.0600 0.0600 0.0900 0.0800
Dividend per Share - - - - - -
Announcement Date 8/9/23 2/14/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - - - 8.4 10 -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - - 3.6 1.6 1.7
ROE (net income / shareholders' equity) - - - 18.2% 15.8% -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - - - 0.7600 0.8900 -
Cash Flow per Share 2 - - - 0.2900 0.1600 -
Capex 1 - - - 0.7 0.7 0.8
Capex / Sales - - - 4.58% 4.02% 4.06%
Announcement Date 2/16/22 2/15/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.02 EUR
Average target price
2.4 EUR
Spread / Average Target
+18.81%
Consensus